Endoxan and liver disorder Patient Reports February 12, 2012

Endoxan Side Effects Report #5334385-9
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on May 17, 2007. Female patient, 29 years of age, was diagnosed with systemic lupus erythematosus and was treated with Endoxan. After drug was administered, patient experienced the following side effects: hyperlipidaemia, jaundice , liver disorder. Endoxan dosage: unknown. During the same period patient was treated with LIVALO, TRICOR, GASTER, PREDONINE, EPADEL, RENIVACE, COMELIAN. Patient was hospitalized. Patient recovered.

Endoxan Side Effects Report #5679112-0
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 03, 2008. Male patient, child 11 years of age, was diagnosed with systemic lupus erythematosus, lupus nephritis, prophylaxis and was treated with Endoxan. After drug was administered, patient experienced the following side effects: c-reactive protein increased, conjunctival hyperaemia, gastric ulcer, headache , lip erosion, liver disorder, nausea , osteoporosis , pyrexia. Endoxan dosage: unknown. During the same period patient was treated with PREDONINE, PREDNISOLONE, UROMITEXAN, GRANISETRON, ALFAROL, GLYCYRON, BREDININ, PERSANTINE. Patient was hospitalized and became disabled. Patient recovered.

Endoxan Side Effects Report #5599692-3
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 14, 2008. Female patient, 23 years of age, was diagnosed with neuropsychiatric lupus and was treated with Endoxan. After drug was administered, patient experienced the following side effects: atrial flutter, cholestasis, hepatocellular injury, hepatojugular reflux, liver disorder. Endoxan dosage: unknown. During the same period patient was treated with MESNA, BACTRIM, ZOLOFT, XANAX, IVERMECTIN, FLUVERMAL. Patient was hospitalized. Patient recovered.

Endoxan Side Effects Report #5916632-5
Endoxan side effect was reported by a Physician from DENMARK on Oct 03, 2008. Male patient, 49 years of age, weighting 176.4 lb, was diagnosed with hodgkin's disease  and was treated with Endoxan. After drug was administered, patient experienced the following side effects: balance disorder, cataract , disease progression, disease recurrence, erectile dysfunction , fatigue, liver disorder, neuralgia. Endoxan dosage: unknown. During the same period patient was treated with CARBOPLATIN, GLUCOCORTICOIDS, METHYL, IFOSFAMIDE, METHOTREXATE, ETOPOSIDE, DEXAMETHASONE, CYTARABINE. Patient recovered.


Endoxan Side Effects Report #5599671-6
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 14, 2008. Male patient, 41 years of age, was diagnosed with glomerulonephritis and was treated with Endoxan. After drug was administered, patient experienced the following side effects: inflammation, influenza like illness, liver disorder. Endoxan dosage: unknown. During the same period patient was treated with IMUREL, CORTANCYL, METHYLPREDNISOLONE, DIFFU, CACIT D, LEVOTHYROX. Patient was hospitalized. Patient recovered.

Endoxan Side Effects Report #5884665-3
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 07, 2008. Female patient, 62 years of age, was diagnosed with breast cancer stage i and was treated with Endoxan. After drug was administered, patient experienced the following side effects: cardiac failure, liver disorder, multi-organ failure, renal failure. Endoxan dosage: unknown. During the same period patient was treated with FARMORUBICIN, FEMARA. Patient died on 05/06/2008.

Endoxan Side Effects Report #4688625-X
Endoxan side effect was reported by a Physician from on June 02, 2005. Female patient, 54 years of age, was diagnosed with breast cancer  and was treated with Endoxan. After drug was administered, patient experienced the following side effects: anorexia, blood bilirubin increased, cardiac tamponade, cardio-respiratory arrest, cardiotoxicity, dyspnoea, haemorrhagic diathesis, liver disorder, malaise. Endoxan dosage: unknown. Patient was hospitalized. Patient died.

Endoxan Side Effects Report #5242774-6
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 08, 2007. Male patient, child 2 years of age, was diagnosed with bone marrow conditioning regimen and was treated with Endoxan. After drug was administered, patient experienced the following side effects: graft versus host disease, liver disorder. Endoxan dosage: unknown. During the same period patient was treated with MABLIN, UROMITEXAN, BAKTAR, LYMPHOGLOBULINE, RIVOTRIL, VICCLOX, KYTRIL, BACCIDAL. Patient was hospitalized. Patient recovered.

Endoxan Side Effects Report #5072817-4
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on July 25, 2006. Male patient, child 10 years of age, was diagnosed with bone marrow conditioning regimen, prophylaxis against transplant rejection, infection prophylaxis and was treated with Endoxan. After drug was administered, patient experienced the following side effects: arthralgia, c-reactive protein increased, diarrhoea, graft versus host disease, hyponatraemia, liver disorder, oral mucosal disorder. Endoxan dosage: unknown. During the same period patient was treated with ZETBULIN, TACROLIMUS, ANTILYMPHOCYTE IMMUNOGLOBULIN, BACTRIM, BROACT, CRAVIT, VALTRAX. Patient was hospitalized. Patient recovered.


Endoxan Side Effects Report #5093076-2
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on July 25, 2006. Male patient, child 10 years of age, was diagnosed with bone marrow conditioning regimen, prophylaxis against transplant rejection, infection prophylaxis and was treated with Endoxan. After drug was administered, patient experienced the following side effects: arthralgia, c-reactive protein increased, diarrhoea, graft versus host disease, hyponatraemia, infection in an immunocompromised host, liver disorder, neutrophil count decreased, oral mucosal disorder. Endoxan dosage: unknown. During the same period patient was treated with METHOTREXATE, ZETBULIN, TACROLIMUS, ANTILYMPHOCYTE IMMUNOGLOBULIN, BACTRIM, BROACT, LEVOFLOXACIN, VALTRAX. Patient was hospitalized. Patient recovered.

Endoxan Side Effects Report #4635907-3
Endoxan side effect was reported by a Consumer or non-health professional from on Apr 04, 2005. Female patient, 71 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Endoxan. After drug was administered, patient experienced the following side effects: liver disorder. Endoxan dosage: unknown. During the same period patient was treated with ONCOVIN, NEUPOGEN. Patient recovered.

Endoxan Side Effects Report #4645897-5
Endoxan side effect was reported by a Consumer or non-health professional from on Apr 04, 2005. Female patient, 71 years of age, was diagnosed with acute lymphocytic leukaemia, neutropenia and was treated with Endoxan. After drug was administered, patient experienced the following side effects: liver disorder. Endoxan dosage: unknown. During the same period patient was treated with ONCOVIN, FILGRASTIM, DAUNORUBICIN, LEUNASE, GASTER, FIRSTCIN, ISEPAMICIN. Patient recovered.

Endoxan Side Effects Report #4657669-6
Endoxan side effect was reported by a Consumer or non-health professional from on Apr 04, 2005. Female patient, 71 years of age, was diagnosed with acute lymphocytic leukaemia, neutropenia and was treated with Endoxan. After drug was administered, patient experienced the following side effects: cholestasis, liver disorder. Endoxan dosage: unknown. During the same period patient was treated with ONCOVIN, FILGRASTIM, DAUNORUBICIN, LEUNASE, GASTER, FIRSTCIN, ISEPAMICIN. Patient recovered.

Endoxan Side Effects Report #4674833-0
Endoxan side effect was reported by a Consumer or non-health professional from on May 19, 2005. Male patient, 68 years of age, was diagnosed with acute lymphocytic leukaemia, bronchopulmonary aspergillosis and was treated with Endoxan. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, cardiac disorder, coma hepatic, gastrointestinal haemorrhage, hepatic encephalopathy, hepatic steatosis, liver disorder, multi-organ failure, renal failure acute. Endoxan dosage: unknown. During the same period patient was treated with METHOTREXATE, FUNGIZONE, ASPARAGINASE, ONCOVIN, CERUBIDINE, VFEND, VALTREX, TAZOBAC. Patient was hospitalized. Patient died on 03/30/2005.